# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-007286
Filing Date
2020-04-29
Accepted
2020-04-28 17:41:47
Documents
64
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm | 10-K | 992629
2 |  | ex4-6.htm | EX-4.6 | 27378
3 |  | ex23-1.htm | EX-23.1 | 5458
4 |  | ex31-1.htm | EX-31.1 | 22145
5 |  | ex31-2.htm | EX-31.2 | 20447
6 |  | ex32-1.htm | EX-32.1 | 11400
7 |  | ex99-1.htm | EX-99.1 | 15415
8 |  | ex23-1_002.jpg | GRAPHIC | 92339
9 |  | ex23-1_001.jpg | GRAPHIC | 22085
| Complete submission text file | 0001493152-20-007286.txt |  | 4043520

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL INSTANCE FILE | ptix-20191231.xml | EX-101.INS | 538299
11 | XBRL SCHEMA FILE | ptix-20191231.xsd | EX-101.SCH | 47287
12 | XBRL CALCULATION FILE | ptix-20191231_cal.xml | EX-101.CAL | 50028
13 | XBRL DEFINITION FILE | ptix-20191231_def.xml | EX-101.DEF | 177579
14 | XBRL LABEL FILE | ptix-20191231_lab.xml | EX-101.LAB | 342787
15 | XBRL PRESENTATION FILE | ptix-20191231_pre.xml | EX-101.PRE | 258824

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51353 | Film No.: 20826363
SIC: 7389 Services-Business Services, NEC